Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 3
2009 1
2010 4
2011 4
2012 8
2013 5
2014 8
2015 4
2016 2
2017 1
2018 1
2019 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Recombinant Activated Coagulation Factor VII on Hemorrhage Expansion Among Patients With Spot Sign-Positive Acute Intracerebral Hemorrhage: The SPOTLIGHT and STOP-IT Randomized Clinical Trials.
Gladstone DJ, Aviv RI, Demchuk AM, Hill MD, Thorpe KE, Khoury JC, Sucharew HJ, Al-Ajlan F, Butcher K, Dowlatshahi D, Gubitz G, De Masi S, Hall J, Gregg D, Mamdani M, Shamy M, Swartz RH, Del Campo CM, Cucchiara B, Panagos P, Goldstein JN, Carrozzella J, Jauch EC, Broderick JP, Flaherty ML; SPOTLIGHT and STOP-IT Investigators and Coordinators. Gladstone DJ, et al. JAMA Neurol. 2019 Dec 1;76(12):1493-1501. doi: 10.1001/jamaneurol.2019.2636. JAMA Neurol. 2019. PMID: 31424491 Free PMC article. Clinical Trial.
The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods.
Kamel H, Longstreth WT Jr, Tirschwell DL, Kronmal RA, Broderick JP, Palesch YY, Meinzer C, Dillon C, Ewing I, Spilker JA, Di Tullio MR, Hod EA, Soliman EZ, Chaturvedi S, Moy CS, Janis S, Elkind MS. Kamel H, et al. Int J Stroke. 2019 Feb;14(2):207-214. doi: 10.1177/1747493018799981. Epub 2018 Sep 10. Int J Stroke. 2019. PMID: 30196789 Free PMC article.
Soluble ST2 predicts outcome and hemorrhagic transformation after acute stroke.
Wolcott Z, Batra A, Bevers MB, Sastre C, Khoury J, Sperling M, Meyer BC, Walsh KB, Adeoye O, Broderick JP, Kimberly WT. Wolcott Z, et al. Ann Clin Transl Neurol. 2017 Jul 5;4(8):553-563. doi: 10.1002/acn3.435. eCollection 2017 Aug. Ann Clin Transl Neurol. 2017. PMID: 28812045 Free PMC article.
Microfluidic manufacture of rt-PA -loaded echogenic liposomes.
Kandadai MA, Mukherjee P, Shekhar H, Shaw GJ, Papautsky I, Holland CK. Kandadai MA, et al. Biomed Microdevices. 2016 Jun;18(3):48. doi: 10.1007/s10544-016-0072-0. Biomed Microdevices. 2016. PMID: 27206512 Free PMC article.
Early Versus Late Assessment of Stroke Outcome.
Lees KR, Selim MH, Molina CA, Broderick JP. Lees KR, et al. Stroke. 2016 May;47(5):1416-9. doi: 10.1161/STROKEAHA.115.011153. Epub 2016 Feb 19. Stroke. 2016. PMID: 26896434 Free PMC article. Review. No abstract available.
Combined Approach to Lysis Utilizing Eptifibatide and Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke-Full Dose Regimen Stroke Trial.
Adeoye O, Sucharew H, Khoury J, Vagal A, Schmit PA, Ewing I, Levine SR, Demel S, Eckerle B, Katz B, Kleindorfer D, Stettler B, Woo D, Khatri P, Broderick JP, Pancioli AM. Adeoye O, et al. Stroke. 2015 Sep;46(9):2529-33. doi: 10.1161/STROKEAHA.115.010260. Epub 2015 Aug 4. Stroke. 2015. PMID: 26243231 Free PMC article. Clinical Trial.
Adopting a Patient-Centered Approach to Primary Outcome Analysis of Acute Stroke Trials Using a Utility-Weighted Modified Rankin Scale.
Chaisinanunkul N, Adeoye O, Lewis RJ, Grotta JC, Broderick J, Jovin TG, Nogueira RG, Elm JJ, Graves T, Berry S, Lees KR, Barreto AD, Saver JL; DAWN Trial and MOST Trial Steering Committees; Additional contributors from DAWN Trial Steering Committee. Chaisinanunkul N, et al. Stroke. 2015 Aug;46(8):2238-43. doi: 10.1161/STROKEAHA.114.008547. Epub 2015 Jul 2. Stroke. 2015. PMID: 26138130 Free PMC article.
Recombinant tissue-type plasminogen activator plus eptifibatide versus recombinant tissue-type plasminogen activator alone in acute ischemic stroke: propensity score-matched post hoc analysis.
Adeoye O, Sucharew H, Khoury J, Tomsick T, Khatri P, Palesch Y, Schmit PA, Pancioli AM, Broderick JP; CLEAR-ER, IMS III, and ALIAS Part 2 Investigators. Adeoye O, et al. Stroke. 2015 Feb;46(2):461-4. doi: 10.1161/STROKEAHA.114.006743. Epub 2014 Dec 18. Stroke. 2015. PMID: 25523054 Free PMC article. Clinical Trial.
Intravenous fibrinolysis eligibility: a survey of stroke clinicians' practice patterns and review of the literature.
De Los Rios F, Kleindorfer DO, Guzik A, Ortega-Gutierrez S, Sangha N, Kumar G, Grotta JC, Lee JM, Meyer BC, Schwamm LH, Khatri P; SPOTRIAS Investigators. De Los Rios F, et al. J Stroke Cerebrovasc Dis. 2014 Sep;23(8):2130-2138. doi: 10.1016/j.jstrokecerebrovasdis.2014.03.024. Epub 2014 Aug 10. J Stroke Cerebrovasc Dis. 2014. PMID: 25113084 Free PMC article.
37 results